Potential Targets' Analysis Reveals Dual PI3K/mTOR Pathway Inhibition as a Promising Therapeutic Strategy for Uterine Leiomyosarcomas—an ENITEC Group Initiative

Overview of attention for article published in Clinical Cancer Research, February 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

So far, Altmetric has seen 8 news stories from 6 outlets.

March 08, 2017 Leiomyosarcomas account for 30% of all uterine sarcomas and are difficult to treat.

March 08, 2017 Leiomyosarcomas account for 30% of all uterine sarcomas and are difficult to treat.

PHILADELPHIA — The protein P-S6S240 may serve as an indicator of poor prognosis for patients with a hard-to-treat type of…

The protein P-S6S240 may serve as an indicator of poor prognosis for patients with a hard-to-treat type of uterine sarcoma…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 4 additional news stories.